Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer

Table 2 Previous studies involving immunohistochemical detection of estrogen receptor-α in non-small cell lung cancer

Ref.	Antibody clone	Location	Detection rates
Omoto et al[6]	NS	Nucleus	67%
Kawai et al[9]	H-150	Nucleus	51%
Schwartz et al[10]	PPG5/10	Nucleus	61%
Wu et al[11]	NS	Nucleus	46%
Márquez-Garbán et al[13]	Polyclonal	Nucleus	52%
		Cytoplasm	69%
Skov et al[14]	PPG5/10	Nucleus	84%
Niikawa et al[15]	MS-ER β13-PX1	Nucleus	90%
Alì et al[26]	PPG5/10	Nucleus	75%
Nose et al[16]	H-150	Nucleus	74%
Raso et al[17]	H-150	Nucleus	56%
		Cytoplasm	98%
	14C8	Nucleus	42%
		Cytoplasm	19%
Abe et al[18]	14C8	Nucleus	71%
Mauro et al[20]	NS	Nucleus	40%
		Cytoplasm	64%
Navaratnam et al[27]	14C8	Nucleus	49%
Rouquette et al[25]	Polyclonal	Nucleus	38%
Karlsson et al[28]	14C8	Nucleus	86%
Liu et al[29]	PPG5/10	Nucleus	45%
		Cytoplasm	59%

NS: Indicates not specified.